Category: Advances in HCV
Cost-Effectiveness and Access to Care in the Treatment of Hepatitis C Virus Infection
Gastroenterology & Hepatology April 2014, Volume 10, Issue 4 Liesl Hagan, MPH candidate Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia G&H Why is the economic […]
Advances in Combination Regimens in the Management of HCV Infection
Gastroenterology & Hepatology February 2014, Volume 10, Issue 2 Advances in Combination Regimens in the Management of HCV Infection Donald M. Jensen, MD, Professor of Medicine, Director, Center […]
Hepatitis C Virus Infection in Special Populations
Hepatitis C Virus Infection in Special Populations Steven L. Flamm, MD, Chief, Liver Transplantation, Professor of Medicine and Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois G&H What do […]
Isotretinoin, Acne, and Crohn’s Disease: A Convergence of Bad Skin, Bad Science, and Bad Litigation Creates the Perfect Storm
CRITICAL VIEWS IN GASTROENTEROLOGY & HEPATOLOGY Isotretinoin, Acne, and Crohn’s Disease: A Convergence of Bad Skin, Bad Science, and Bad Litigation Creates the Perfect Storm The consequences of […]
Interferon-free Regimens and Direct-Acting Antiviral Agents
Paul J. Pockros, MD Director of the Center for Liver Diseases Division of Gastroenterology and Hepatology Scripps Clinic Director of Clinical Research Scripps Translational Science Institute […]
FibroScan in the Diagnosis of Hepatitis C Virus Infection
Nezam H. Afdhal, MD Director of Hepatology Beth Israel Deaconess Medical Center Professor of Medicine Harvard Medical School Boston, Massachusetts G&H Why is the evaluation of […]